Salicylhydroxamic acid
Names | |
---|---|
Preferred IUPAC name
N,2-Dihydroxybenzamide | |
Other names
2-Hydroxybenzenecarbohydroxamic acid
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.001.759 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C7H7NO3 | |
Molar mass | 153.137 g·mol−1 |
Appearance | Brownish crystalline powder |
Melting point | 175 to 178 °C (347 to 352 °F; 448 to 451 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Salicylhydroxamic acid (SHA or SHAM) is a drug that is a potent and irreversible enzyme inhibitor of the urease enzyme in various bacteria and plants; it is usually used for urinary tract infections. The molecule is similar to urea but is not hydrolyzable by urease;[1] it thus disrupts the bacteria's metabolism through competitive inhibition. It is also a trypanocidal agent. When administered orally, it is metabolized to salicylamide, which exerts analgesic, antipyretic, and anti-inflammatory effects.[citation needed]
Salicylhydroxamic acid is also a common ligand utilized in the synthesis of metallacrowns.[citation needed]
In plants, some fungi and some protists with the
African Sleeping Sickness, meaning that SHAM completely shuts down oxygen consumption by this organism.[3][4]
See also
References